Statistics for Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts
Total visits
views | |
---|---|
Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts | 163 |
Total visits per month
views | |
---|---|
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
File Visits
views | |
---|---|
oncotarget-10-2709.pdf | 128 |
Top country views
views | |
---|---|
United States | 113 |
Germany | 7 |
Ukraine | 6 |
United Kingdom | 3 |
Canada | 2 |
Sweden | 2 |
China | 1 |
France | 1 |
Malaysia | 1 |
Portugal | 1 |
Top city views
views | |
---|---|
Wilmington | 45 |
Fairfield | 13 |
Houston | 9 |
Cambridge | 6 |
Kiev | 6 |
Jacksonville | 5 |
Kiez | 4 |
Ann Arbor | 2 |
Chicago | 2 |
Coburg | 2 |
Stockholm | 2 |
Toronto | 2 |
Brooklyn | 1 |
Commack | 1 |
Gunzenhausen | 1 |
Kansas City | 1 |
Linda-a-velha | 1 |
Ling | 1 |
Roubaix | 1 |
Saint Louis | 1 |
San Francisco | 1 |
Scottsdale | 1 |
Seremban | 1 |